Montrusco Bolton Investments Inc. raised its position in CME Group Inc (NASDAQ:CME) by 10.7% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 140,612 shares of the financial services provider’s stock after purchasing an additional 13,603 shares during the period. CME Group comprises about 1.7% of Montrusco Bolton Investments Inc.’s investment portfolio, making the stock its 21st largest position. Montrusco Bolton Investments Inc.’s holdings in CME Group were worth $26,466,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in CME. Advantage Investment Management LLC increased its position in CME Group by 119.0% during the 2nd quarter. Advantage Investment Management LLC now owns 184 shares of the financial services provider’s stock worth $36,000 after purchasing an additional 100 shares in the last quarter. Westside Investment Management Inc. acquired a new stake in CME Group during the 2nd quarter worth approximately $38,000. Close Asset Management Ltd acquired a new stake in CME Group during the 1st quarter worth approximately $34,000. Permanens Capital L.P. acquired a new stake in CME Group during the 1st quarter worth approximately $41,000. Finally, Next Capital Management LLC increased its position in CME Group by 350.0% during the 2nd quarter. Next Capital Management LLC now owns 297 shares of the financial services provider’s stock worth $58,000 after purchasing an additional 231 shares in the last quarter. Institutional investors and hedge funds own 85.72% of the company’s stock.

In other news, Director Timothy S. Bitsberger sold 700 shares of the firm’s stock in a transaction that occurred on Tuesday, June 4th. The shares were sold at an average price of $194.35, for a total transaction of $136,045.00. Following the completion of the sale, the director now owns 9,421 shares of the company’s stock, valued at $1,830,971.35. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Terrence A. Duffy sold 35,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $200.15, for a total transaction of $7,005,250.00. Following the sale, the chief executive officer now directly owns 79,057 shares of the company’s stock, valued at approximately $15,823,258.55. The disclosure for this sale can be found here. Insiders have sold 82,363 shares of company stock valued at $16,429,225 in the last three months. Corporate insiders own 1.20% of the company’s stock.

A number of analysts recently issued reports on CME shares. Deutsche Bank increased their target price on shares of CME Group from $224.00 to $240.00 and gave the stock a “buy” rating in a research report on Friday, August 9th. UBS Group increased their target price on shares of CME Group from $190.00 to $194.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 3rd. Citigroup set a $202.00 target price on shares of CME Group and gave the stock a “buy” rating in a research report on Thursday, May 2nd. Wells Fargo & Co increased their price objective on shares of CME Group from $176.00 to $200.00 and gave the company a “market perform” rating in a research report on Wednesday, July 3rd. Finally, Zacks Investment Research downgraded shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 price objective for the company. in a research report on Monday, May 27th. Three research analysts have rated the stock with a sell rating, five have issued a hold rating and eight have issued a buy rating to the company’s stock. CME Group has a consensus rating of “Hold” and a consensus target price of $194.00.

NASDAQ:CME traded up $2.25 during trading hours on Monday, hitting $215.83. The stock had a trading volume of 20,896 shares, compared to its average volume of 1,380,286. CME Group Inc has a 1-year low of $161.05 and a 1-year high of $216.73. The company has a current ratio of 1.05, a quick ratio of 1.05 and a debt-to-equity ratio of 0.15. The company has a market cap of $75.97 billion, a PE ratio of 31.59, a price-to-earnings-growth ratio of 4.74 and a beta of 0.23. The business has a 50 day simple moving average of $204.44 and a two-hundred day simple moving average of $186.30.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share for the quarter, topping analysts’ consensus estimates of $1.75 by $0.01. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The business had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.27 billion. During the same quarter last year, the company earned $1.74 earnings per share. The business’s quarterly revenue was up 20.1% compared to the same quarter last year. Research analysts expect that CME Group Inc will post 6.68 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Tuesday, September 10th will be given a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.39%. The ex-dividend date is Monday, September 9th. CME Group’s payout ratio is currently 43.99%.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Read More: How to Invest in Marijuana Stocks

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.